Position in GILD
as of Mar 31, 2026
· filed Apr 17, 2026
Position Value
$200,135
New position
Shares Held
1,436
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Telos Capital Management, Inc. holds $41,593,885 across 9 Drug Manufacturers - General names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
46,049 | $11,695,064 | |
| 2 | AMGN |
Amgen Inc
|
25,990 | $9,411,498 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
111,780 | $6,440,763 | |
| 4 | ABBV |
AbbVie Inc.
|
18,380 | $4,625,143 | |
| 5 | NVS |
Novartis AG
|
25,483 | $3,993,695 | |
| 6 | LLY |
ELI LILLY & Co
|
2,302 | $2,761,088 | |
| 7 | MRK |
Merck & Co., Inc.
|
14,035 | $1,803,497 | |
| 8 | PFE |
Pfizer Inc
|
25,954 | $624,972 |
All Filings in GILD
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $200,135 | 1,436 | Shares | Sole | 2026-04-17 | |
| No filing history on record for this holder in this stock. | ||||||